Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Clonidine vs IV Tranexamic Acid for Blood Loss in Cesarean Section
NCT05371574Phase 1Unknown
- Start
- Jan 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Clonidine Lauriad in hemorrhage (2 arms). Primary endpoint: Blood loss at 6 months. Status: unknown.
02
Drugs
Clonidine Lauriad
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05371574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05371574.